DICE Therapeutics, Inc.
DICEDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted in 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by DICE Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for DICE Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| RA Capital Healthcare Fund LP | Other: Former 10% owners and Director | 0Indirect | Aug 9, 2023 | 0 |
| Ra Capital Management, L.P. | Other: Former 10% owners and Director | 0Indirect | Aug 9, 2023 | 0 |
| Kolchinsky Peter | Other: Former 10% owners and Director | 0Indirect | Aug 9, 2023 | 0 |
| Shah Rajeev M. | Other: Former 10% owners and Director | 0Indirect | Aug 9, 2023 | 0 |
| RA Capital Nexus Fund II, L.P. | Other: Former 10% owners and Director | 0Indirect | Aug 9, 2023 | 0 |
| Scheller Richard H | Director | 0 | Aug 9, 2023 | 0 |
| Tetlow Sharon | Director | 0 | Aug 9, 2023 | 0 |
| Scopa James Paul | Director | 0Indirect | Aug 9, 2023 | 0 |
| Judice Kevin | CEO | 0 | Aug 9, 2023 | 0 |
| Simson Jake | Director | – | Aug 9, 2023 | 0 |
| Timothy Lu | CMO | 0 | Aug 9, 2023 | 0 |
| Jacobsen John R. | CSO | 0 | Aug 9, 2023 | 0 |
| Robertson Scott M. | CFO & CBO | 0 | Aug 9, 2023 | 0 |
| Bowers Lisa | Director | – | Aug 9, 2023 | 0 |
| Doyle Mittie | Director | – | Aug 9, 2023 | 0 |
| Northpond Ventures GP, LLC | 10% Owner | 166,293Indirect | Jun 23, 2023 | 0 |
| Northpond Ventures, LP | 10% Owner | 166,293Indirect | Jun 23, 2023 | 0 |
| Rubin Michael P. | 10% Owner | 166,293Indirect | Jun 23, 2023 | 0 |
| Northpond Ventures II GP, LLC | 10% Owner | 166,293Indirect | Jun 23, 2023 | 0 |
| Northpond Ventures II, LP | 10% Owner | 166,293Indirect | Jun 23, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 (view filing)5:36 PM ET | Jun 22 | 1 day | Northpond Ventures GP, LLC and 4 others10% Owner | SSale | −2.49M | $46.50 | −$115.9M | −93.7%166.3K after | 2 lots |
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | Jacobsen John R.CSO | SSale | −18.8K | $30.53 | −$572.4K | −11.3%147.5K after | 2 lots |
| May 9, 2023 (view filing) | May 5 | 4 days | Scheller Richard HDirector | SSale | −84.1K | $38.51 | −$3.24M | −90.9%8.43K after | |
| May 5, 2023 (view filing) | May 3 | 2 days | Robertson Scott M.CFO & CBO | SSale | −18.8K | $36.55 | −$685.3K | −8.7%198.0K after | |
| May 5, 2023 (view filing) | May 3 | 2 days | Timothy LuCMO | SSale | −10.0K | $36.54 | −$365.4K | −6.2%152.3K after | |
| May 5, 2023 (view filing) | May 3 | 2 days | Judice KevinCEO | SSale | −13.7K | $36.50 | −$500.0K | −1.7%799.7K after | |
| Apr 19, 2023 (view filing) | Apr 18 | 1 day | Jacobsen John R.CSO | SSale | −16.4K | $30.08 | −$493.1K | −9.0%166.2K after | |
| Apr 4, 2023 (view filing) | Mar 31 | 4 days | Jacobsen John R.CSO | SSale | −773 | $30.00 | −$23.2K | −0.4%182.6K after | |
| Mar 30, 2023 (view filing)5:03 PM ET | Mar 28-30 | 2 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | PPurchase | +509.1K | $29.07 | +$14.8M | +7.8%7.07M after | 3 lots |
| Mar 30, 2023 (view filing) | Mar 28-29 | 2 days | Jacobsen John R.CSO | SSale | −1.59K | $30.03 | −$47.9K | −0.9%183.4K after | 2 lots |
| Mar 27, 2023 (view filing)5:01 PM ET | Mar 23-27 | 4 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | PPurchase | +498.6K | $26.99 | +$13.5M | +8.2%6.56M after | 3 lots |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Scopa James PaulDirector | SSale | −10.0K | $29.05 | −$290.5K | −29.7%23.7K after | |
| Oct 19, 2022 (view filing)4:32 PM ET | Oct 17 | 2 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | PPurchase | +1.64M | $36.50 | +$59.9M | +31.5%6.85M after | |
| Sep 20, 2021 (view filing)9:19 PM ET | Sep 17 | 3 days | Northpond Ventures GP, LLC and 4 others10% Owner | PPurchase | +235.0K | $17.00 | +$4.00M | +7.7%3.29M after | |
| Sep 20, 2021 (view filing)4:30 PM ET | Sep 17 | 3 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | PPurchase | +1.40M | $17.00 | +$23.8M | New position786.4K after | 2 lots |
| Sep 16, 2021 (view filing) | Sep 15 | 1 day | Scopa James PaulDirector | PPurchase | +6.00K | $17.00 | +$102.0K | +12.0%55.8K after |